查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2028 年膀胱過度活動症治療市場預測—COVID-19影響以及按藥物療法和疾病類型進行的全球分析
市場調查報告書
商品編碼
1153722

2028 年膀胱過度活動症治療市場預測—COVID-19影響以及按藥物療法和疾病類型進行的全球分析

Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy and Disease Type
出版日期: | 出版商: The Insight Partners | 英文 209 Pages | 訂單完成後即時交付

價格

全球膀胱過度活動症治療市場預計將從 2021 年的 42.9593 億美元增長到 2028 年的 53.3392 億美元。據估計，從 2022 年到 2028 年，複合年增長率將達到 3.1%。

膀胱過度活動症 (OAB) 是指難以控制的頻繁和突然的排尿衝動。 OAB 可由腹部創傷、感染、神經損傷和某些藥物引起。 OAB 在 65 歲以上的人群中很常見。女性可能在 45 歲後患上 OAB。治療可能包括改變某些行為、藥物和神經刺激。根據美國尿失禁協會的數據，2018 年全球約有 2 億人受到尿失禁的影響。影響女性的尿失禁包括壓力性尿失禁和急迫性尿失禁，後者也稱為膀胱過度活動症。

同樣，美國醫學協會和美國傳染病學會的一組研究人員在 2020 年進行的一項研究發現，美國每年約有 600 萬醫生因尿路感染 (UTI) 就診。據稱在加拿大，每年約有 500,000 人因 UTI 去看醫生。在加拿大，尿路感染分別是就診門診和急診的第八大和第五大常見原因。因此，尿失禁患病率的增加和尿路感染髮病率的增加正在推動膀胱過度活動症治療市場。

膀胱過度活動症治療市場分為藥物療法、疾病類型和地區。按地域劃分，大致分為北美、歐洲、亞太、中東/非洲、中南美洲。膀胱過度活躍治療市場報告重點介紹了市場趨勢、市場動態和全球主要市場參與者的競爭分析等參數，提供了市場考慮和深入分析。

基於藥物治療，膀胱過度活動症治療市場分為米拉貝隆、肉毒桿菌、神經刺激、抗膽鹼能藥和膀胱內滴注。米拉貝隆細分市場預計將在 2021 年佔據最大的市場份額，並在預測期內實現最高的複合年增長率。米拉貝隆單獨使用或與索利那新一起用於治療成人膀胱過度活動症。它還用於治療 3 歲及以上兒童的神經源性交叉膀胱過度活動症（一種由大腦、脊髓或神經問題引起的膀胱控制狀況）。米拉貝隆屬於一類稱為 BETA3 腎上腺素能激動劑的藥物。此藥可使膀胱肌肉鬆弛，防止尿急、尿急。米拉貝隆有緩釋片劑（長效）和可口服的緩釋混懸劑兩種形式。 2022 年 10 月，Zydus Pharmaceuticals, Inc. 獲得 USFDA 的米拉貝隆緩釋片 USP 25mg 和 50mg 上市許可。

COVID-19 的爆發為膀胱過度活動症治療市場的參與者提供了幾個有利的場景。美國是北美最具影響力的國家。這種傳染病嚴重影響了該國的人口老齡化，導致各種並發症並導致許多人死亡。例如，截至 2022 年 5 月 16 日，美國報告的 COVID 病例為 84,230,829 例，死亡 1,026,670 例。因此，膀胱過度活動症的治療和適當的護理對於預防慢性感染和疾病是必要的。

COVID-19 爆發後，膀胱過度活動症的發病率有所增加。美國泌尿外科協會的一項研究發現，感染 COVID-19 的患者出現膀胱過度活動症的新症狀或症狀惡化的風險增加。此外，大約三分之一的 COVID-19 患者在感染兩個月後進行的國際失禁問卷調查膀胱過度活動症模塊 (ICIQ-OAB) 中報告臨床症狀顯著增加。這些患者中有三分之一，即大約五分之一，報告了 OAB 的新症狀。 COVID-19導致膀胱過度活動症患病率上升，這對大流行期間膀胱過度活動症治療的需求產生了積極影響。

在準備有關膀胱過度活動症治療市場的報告時，主要的主要和次要來源包括世界衛生組織 (WHO)、疾病控制和預防中心 (CDC) 以及美國國務院婦女健康辦公室使用了健康與公共服務。參考了以下信息：

內容

第一章介紹

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球膀胱過度活動症治療市場——藥物療法
    • 全球膀胱過度活動症治療市場 - 按疾病類型
    • 全球膀胱過度活動症治療市場：按地區

第 2 章膀胱過度活動症治療的全球市場：要點

第三章研究方法論

  • 調查對象
  • 二次調查
  • 初步調查

第 4 章膀胱過度活動症治療的全球市場：市場格局

  • 害蟲分析
    • 北美 - PEST 分析
    • 歐洲 - PEST 分析
    • 亞太地區 - PEST 分析
    • 拉丁美洲 - PEST 分析
    • 中東和非洲 PEST 分析
  • 專家意見

第 5 章膀胱過度活動症治療市場：主要市場動態

  • 市場驅動力
    • 尿失禁患病率增加
    • 增加尿路感染的發生率
  • 主要市場製約因素
    • 治療藥物召回
  • 主要市場機會
    • 併購增加
  • 未來趨勢
    • 強大的藥物管線和連續推出的新藥
  • 影響分析

第 6 章膀胱過度活動症治療的全球市場：全球分析

  • 膀胱過度活動症治療全球市場收入、預測和分析
    • 膀胱過動症治療全球市場收入預測和分析
    • 全球膀胱過度活動症治療市場 - 市場潛力分析，按地區
    • 公司分析
  • 比較公司分析
    • 增長戰略分析
    • 膀胱過度活動症治療市場主要參與者的市場定位
      • 安斯泰來製藥公司
      • Allagan PLC

第 7 章膀胱過度活動症治療市場分析和到 2028 年的預測：藥物療法

  • 按藥物療法劃分的 2021 年和 2028 年膀胱過度活動症治療的全球市場 (%)
  • 米拉貝隆
  • 保妥適
  • 神經刺激
  • 抗膽鹼藥
  • 膀胱內輸液

第 8 章膀胱過度活動症治療市場分析和到 2028 年的預測：按疾病類型分類

  • 膀胱過度活動症治療的全球市場：2021 年和 2028 年按疾病類型分類 (%)
  • 特發性膀胱過度活動症
  • 神經源性膀胱過度活動症

第 9 章膀胱過度活動症治療市場收入和到 2028 年的預測：區域分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
    • 阿聯酋
    • 沙特阿拉伯
    • 南非
    • 其他中東地區
  • 拉丁美洲
      • 巴西
    • 阿根廷
      • 其他拉丁美洲

第 10 章 COVID-19 大流行對膀胱過度活動症治療市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第 11 章膀胱過度活動症治療市場：行業格局

  • 市場參與者實施的增長戰略 (%)
  • 有機部署

第12章公司簡介

  • Alembic Pharmaceuticals Limited
  • Astellas Pharma Inc
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd
  • Endo Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Medtronic Plc
  • Colorado Urology Associates, PLLC
  • Axonics Modulation Technologies, Inc

第13章附錄

  • 關於 Insight Partners
  • 詞彙表
Product Code: TIPRE00004082

The global overactive bladder treatment market is expected to grow from US$ 4,295.93 million in 2021 to US$ 5,333.92 million by 2028. It is estimated to grow at a CAGR of 3.1% from 2022 to 2028.

Overactive bladder (OAB) is the frequent and sudden urge to urinate, which might be difficult to control. OAB can be caused due to abdominal trauma, infection, nerve damage, and certain medications. OAB is common in people aged 65 and older. Women may have OAB after 45 years. The treatment includes changing certain behaviors, medications, and nerve stimulation. According to the National Association for Incontinence data, in 2018, ~200 million people worldwide were affected by urinary incontinence. Stress incontinence and urge incontinence are the two common types of urinary incontinence affecting women, wherein the latter is also known as overactive bladder.

Similarly, a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020 stated that urinary tract infection (UTI) was the cause of ~6 million physician visits each year in the US. In Canada, ~500,000 visits to the doctor's office are for UTI consultations annually. UTI is the eighth and fifth most common reason for ambulatory clinic visits and emergency department visits, respectively, in the country. Thus, increasing prevalence of urinary incontinence and growing incidence of urinary tract infections are driving the overactive bladder treatment market.

The overactive bladder treatment market is segmented into pharmacotherapy, disease type, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The overactive bladder treatment market report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.

Based on pharmacotherapy, the overactive bladder treatment market is segmented into mirabegron, Botox, neurostimulation, anticholinergics, and intravesical instillation. The mirabegron segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period. Mirabegron is used alone or with solifenacin to treat overactive bladder in adults. It is used to treat neurogenic detrusor overactivity (a bladder control condition caused by the brain, spinal cord, or nerve problem) in children aged three years or more. Mirabegron belongs to the class of drugs called beta-3 adrenergic agonists. It relaxes the bladder muscles to prevent urgent, frequent, or uncontrolled urination. Mirabegron is available as an extended-release (long-acting) tablet and an extended-release suspension that can be taken orally. In October 2022, Zydus Pharmaceuticals Inc. received approval from the USFDA to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg.

The COVID-19 pandemic has shown some favorable scenarios for players operating in the overactive bladder treatment market. The US was the highly affected country in North America. The infection severely affected the geriatric population in the country, causing various complications and leading to the death of a large population. For instance, as of May 16, 2022, the US reported 84,230,829 COVID cases with 1,026,670 deaths. Therefore, overactive bladder treatment and proper care are required to prevent chronic cases of infection and health conditions.

After the COVID-19 outbreak, there has been an increase in the occurrence of OAB. According to a study by American Urological Association, patients with COVID-19 infections were at an increased risk for developing new or worsening overactive bladder symptoms. Moreover, approximately one-third of patients with COVID-19 reported a significant increase in clinical symptoms during the International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB) conducted two months after infection. Out of these one-third of patients, approximately 1 in 5 patients, reported that their OAB symptoms were new. This increased prevalence of OAB due to COVID-19 positively impacted the demand for overactive bladder treatment during the pandemic.

Some of the key primary and secondary sources referred to while preparing the report on the overactive bladder treatment market are the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the Office on Women's Health-a division of US Department of Health and Human Services, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the overactive bladder treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global overactive bladder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the overactive bladder treatment market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Overactive Bladder Treatment Market- By Pharmacotherapy
    • 1.3.2 Global Overactive Bladder Treatment Market- By Disease Type
    • 1.3.3 Global Overactive Bladder Treatment Market - By Geography

2. Global Overactive Bladder Treatment Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Overactive Bladder Treatment Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 South & Central America - PEST Analysis
    • 4.2.5 Middle East & Africa - PEST Analysis
  • 4.3 Expert Opinion

5. Overactive Bladder Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Prevalence of Urinary Incontinence
    • 5.1.2 Growing Incidence of Urinary Tract Infections
  • 5.2 Key Market Restraints
    • 5.2.1 Recalls of Therapeutic Drugs
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Number of Mergers and Acquisitions
  • 5.4 Future Trends
    • 5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies
  • 5.5 Impact analysis

6. Global Overactive Bladder Treatment Market - Global Analysis

  • 6.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
    • 6.1.1 Global Overactive Bladder Treatment Market Revenue Forecast and Analysis
    • 6.1.2 Global Overactive Bladder Treatment Market - Market Potential Analysis, By Region
    • 6.1.3 Company Analysis
  • 6.2 Comparative Company Analysis
    • 6.2.1 Growth Strategy Analysis
    • 6.2.2 Market Positioning of Key Players in the Overactive Bladder Treatment Market
      • 6.2.2.1 Astellas Pharma Inc.
      • 6.2.2.2 Allergan Plc

7. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Pharmacotherapy

  • 7.1 Overview
  • 7.2 Global Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)
  • 7.3 Mirabegron
    • 7.3.1 Overview
    • 7.3.2 Mirabegron Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Botox
    • 7.4.1 Overview
    • 7.4.2 Botox Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Neurostimulation
    • 7.5.1 Overview
    • 7.5.2 Neurostimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.3 Transcutaneous Sacral Nerve Stimulation
      • 7.5.3.1 Overview
      • 7.5.3.2 Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.4 Transcutaneous Tibial Nerve Stimulation
      • 7.5.4.1 Overview
      • 7.5.4.2 Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.5 Percutaneous Posterior Tibial Nerve Stimulation
      • 7.5.5.1 Overview
      • 7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.5.6 Others
      • 7.5.6.1 Overview
      • 7.5.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Anticholinergics
    • 7.6.1 Overview
    • 7.6.2 Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.3 Solifenacin
      • 7.6.3.1 Overview
      • 7.6.3.2 Solifenacin Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.4 Oxybutynin
      • 7.6.4.1 Overview
      • 7.6.4.2 Oxybutynin Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.5 Fesoterodine
      • 7.6.5.1 Overview
      • 7.6.5.2 Fesoterodine Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.6 Darifenacin
      • 7.6.6.1 Overview
      • 7.6.6.2 Darifenacin Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.7 Tolterodine
      • 7.6.7.1 Overview
      • 7.6.7.2 Tolterodine Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.8 Trospium
      • 7.6.8.1 Overview
      • 7.6.8.2 Trospium Market Revenue and Forecast to 2028 (US$ Million)
    • 7.6.9 Other Anticholinergics
      • 7.6.9.1 Overview
      • 7.6.9.2 Other Anticholinergics Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Intravesical Instillation
    • 7.7.1 Overview
    • 7.7.2 Intravesical Instillation Market Revenue and Forecast to 2028 (US$ Mn)

8. Overactive Bladder Treatment Market Analysis and Forecasts To 2028 - By Disease Type

  • 8.1 Overview
  • 8.2 Global Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)
  • 8.3 Idiopathic Overactive Bladder
    • 8.3.1 Overview
    • 8.3.2 Idiopathic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Neurogenic Overactive Bladder
    • 8.4.1 Overview
    • 8.4.2 Neurogenic Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 9.1 North America: Overactive Bladder Treatment Market
    • 9.1.1 Overview
    • 9.1.2 North America: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
    • 9.1.3 North America: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
      • 9.1.3.1 North America: Overactive Bladder Treatment Market, by Anticholinergics- Revenue and Forecast to 2028 (US$ Million)
      • 9.1.3.2 North America: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
    • 9.1.4 North America: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
    • 9.1.5 North America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.1.5.1 US: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.1 US: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2 US: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2.1 US: Overactive Bladder Treatment Market, by Anticholinergics- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2.2 US: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.3 US: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
      • 9.1.5.2 Canada: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.1 Canada: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2 Canada: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2.1 Canada: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2.2 Canada: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.3 Canada: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
      • 9.1.5.3 Mexico: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.1 Mexico: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2 Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2.1 Mexico: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2.2 Mexico: Overactive Bladder Treatment Market, by Neurostimulation- Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.3 Mexico: Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (US$ Million)
  • 9.2 Europe: Overactive Bladder Treatment Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.3 Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.3.1 Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.3.2 Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.4 Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.5 Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.2.5.1 UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.1 UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2 UK: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2.1 UK: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2.2 UK: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.3 UK: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.2 Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.1 Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2 Germany: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2.1 Germany: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2.2 Germany: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.3 Germany: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.3 France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.1 France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2 France: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2.1 France: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2.2 France: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.3 France: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.4 Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.1 Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2 Italy: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2.1 Italy: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2.2 Italy: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.3 Italy: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.5 Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.1 Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2 Spain: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2.1 Spain: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2.2 Spain: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.3 Spain: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
      • 9.2.5.6 Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.1 Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2 Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2.1 Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2.2 Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.3 Rest of Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Asia Pacific: Overactive Bladder Treatment Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.3.3 Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
      • 9.3.3.1 Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
      • 9.3.3.2 Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    • 9.3.4 Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
    • 9.3.5 Asia Pacific: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.3.5.1 China: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.1.1 China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.2 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.1 Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.3 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.3.1 India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.4 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.1 South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.5 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.1 Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.3.5.6 Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.1 Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.2 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.3.5.6.2.1 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.3.5.6.2.2 Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.3.5.6.3 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  • 9.4 Middle East & Africa: Overactive Bladder Treatment Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.4.3 Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
      • 9.4.3.1 Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
      • 9.4.3.2 Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    • 9.4.4 Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
    • 9.4.5 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.4.5.1 UAE: overactive bladder treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.1.1 UAE: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.4.5.2 Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.1 Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.4.5.3 South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.3.1 South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
      • 9.4.5.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (US$ Million)
        • 9.4.5.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.4.5.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.4.5.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (US$ Million)
  • 9.5 South and Central America: Overactive Bladder Treatment Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 9.5.3 South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
      • 9.5.3.1 South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
      • 9.5.3.2 South & Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
    • 9.5.4 South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
    • 9.5.5 South and Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
      • 9.5.5.1 Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.2 Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.3 Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
        • 9.5.5.3.1.1 Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.5.5.3.1.2 Brazil Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
      • 9.5.5.4 Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
    • 9.5.6 Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 9.5.6.1 Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.1.1 Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
        • 9.5.6.1.1.1 Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.5.6.1.1.2 Argentina Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.1.2 Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)
      • 9.5.6.2 Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.2.1 Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.2.2 Rest of South and Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2028 (USD Million)
        • 9.5.6.2.2.1 Rest of South and Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019-2028 (US$ Million)
        • 9.5.6.2.2.2 Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (USD Million)
        • 9.5.6.2.3 Rest of South and Central America: Overactive Bladder Treatment Market, by Disease Type, 2019-2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Overactive Bladder Treatment Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 South & Central America: Impact Assessment of COVID-19 Pandemic
  • 10.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11. Overactive Bladder Treatment Market- Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Alembic Pharmaceuticals Limited
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Astellas Pharma Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AbbVie Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Teva Pharmaceutical Industries Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Endo Pharmaceuticals Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Hisamitsu Pharmaceutical Co.,Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medtronic Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Colorado Urology Associates, PLLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Axonics Modulation Technologies, Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. UK: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. UK: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Germany: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Germany: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Germany: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Germany: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. France: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. France: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. France: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. France: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Italy: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Italy: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Italy: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Italy: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Spain: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Spain: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Spain: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Spain: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Rest of Europe: Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Asia Pacific Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. China Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. China Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. China Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. China Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Japan Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Japan Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Japan Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Japan Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. India Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. India Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. India Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. India Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. South Korea Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. South Korea Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Korea Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Australia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Australia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Australia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Australia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Asia Pacific Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. UAE Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. UAE Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. South Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. South Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. South Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy- Revenue and Forecast to 2028 (USD Million)
  • Table 94. South and Central America Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. South and Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. South and Central America Overactive Bladder Treatment Market, by Disease Type- Revenue and Forecast to 2028 (USD Million)
  • Table 97. Brazil Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
  • Table 98. Brazil Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. Brazil Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. Brazil Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 101. Argentina Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
  • Table 102. Argentina Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. Argentina Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. Argentina Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 105. Rest of South and Central America Overactive Bladder Treatment Market, by Pharmacotherapy - Revenue and Forecast to 2028 (USD Million)
  • Table 106. Rest of South and Central America Overactive Bladder Treatment Market, by Anticholinergic - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. Rest of South and Central America Overactive Bladder Treatment Market, by Neurostimulation - Revenue and Forecast to 2028 (US$ Million)
  • Table 108. Rest of South and Central America Overactive Bladder Treatment Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)
  • Table 109. Organic Developments Done by Companies
  • Table 110. Glossary of Terms

List Of Figures

  • Figure 1. Global Overactive Bladder Treatment Market Segmentation
  • Figure 2. Global Overactive Bladder Treatment Market Segmentation, By Region
  • Figure 3. Global Overactive Bladder Treatment Market Overview
  • Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Overactive Bladder Treatment market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Overactive Bladder Treatment Market, By Geography (US$ Million)
  • Figure 7. Global Overactive Bladder Treatment Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Overactive Bladder Treatment Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. South & Central America: PEST Analysis
  • Figure 13. Middle East & Africa: PEST Analysis
  • Figure 14. Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints
  • Figure 15. Global Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Global Overactive Bladder Treatment Market - Revenue Forecast and Analysis - 2021- 2028
  • Figure 17. Global Overactive Bladder Treatment Market - Market Potential Analysis, By Region
  • Figure 18. Analysis of Key Players in Overactive Bladder Treatment Market
  • Figure 19. Global Overactive Bladder Treatment Market - Comparative Company Analysis
  • Figure 20. Global Overactive Bladder Treatment Market - Growth Strategy Analysis
  • Figure 21. Global Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)
  • Figure 22. Mirabegron Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 23. Botox Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. Neurostimulation Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Transcutaneous Sacral Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 26. Transcutaneous Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 27. Percutaneous Posterior Tibial Nerve Stimulation Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 28. Others Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 29. Anticholinergics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 30. Solifenacin Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31. Oxybutynin Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 32. Fesoterodine Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 33. Darifenacin Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34. Tolterodine Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 35. Trospium Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 36. Other Anticholinergics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 37. Intravesical Instillation Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 38. Global Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)
  • Figure 39. Idiopathic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 40. Neurogenic Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 41. North America: Overactive Bladder Treatment Market Revenue Overview, By Key Country - Revenue (2021) (US$ Million)
  • Figure 42. North America: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 43. North America: Overactive Bladder Treatment Market, By Country, 2021 & 2028 (%)
  • Figure 44. US: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 45. Canada: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 46. Mexico: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 47. Europe: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 48. Europe: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)
  • Figure 50. UK: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Germany: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. France: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Italy: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Spain: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Rest of Europe: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Asia Pacific: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 57. Asia Pacific Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 58. China: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Japan: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. India: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. South Korea: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Australia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Rest of Asia Pacific: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 65. Middle East & Africa Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 66. UAE: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Saudi Arabia: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. South Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Rest of Middle East & Africa: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. South and Central America: Overactive Bladder Treatment Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 71. South and Central America Overactive Bladder Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 72. Brazil: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 73. Argentina: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Rest of South and Central America: Overactive Bladder Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 76. Impact of COVID-19 Pandemic in European Countries Markets
  • Figure 77. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 78. Impact of COVID-19 Pandemic on South and Central America Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 80. Growth Strategies Done by the Companies in the Market, (%)